Hippocampal interneuron loss and plasticity in human temporal lobe epilepsy
NC De Lanerolle, JH Kim, RJ Robbins, DD Spencer - Brain research, 1989 - Elsevier
It has been hypothesized on the basis of animal models of epilepsy that abnormal neural
activity in epilepsy may be related to reorganized neural circuits that facilitate epileptogenesis. …
activity in epilepsy may be related to reorganized neural circuits that facilitate epileptogenesis. …
A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma
EL Mazzaferri, RJ Robbins, CA Spencer… - The Journal of …, 2003 - academic.oup.com
Recent studies have provided new information regarding the optimal surveillance protocols
for low-risk patients with differentiated thyroid cancer (DTC). This article summarizes the …
for low-risk patients with differentiated thyroid cancer (DTC). This article summarizes the …
Real-Time Prognosis for Metastatic Thyroid Carcinoma Based on 2-[18F]Fluoro-2-Deoxy-d-Glucose-Positron Emission Tomography Scanning
RJ Robbins, Q Wan, RK Grewal… - The Journal of …, 2006 - academic.oup.com
Context/Objective: Approximately 15% of thyroid cancer patients develop subsequent metastases.
The clinical course of patients with metastatic thyroid carcinoma is highly variable. We …
The clinical course of patients with metastatic thyroid carcinoma is highly variable. We …
[HTML][HTML] Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease
DD Spencer, RJ Robbins, F Naftolin… - … England Journal of …, 1992 - Mass Medical Soc
Background. Parkinson's disease is characterized by the loss of midbrain dopamine
neurons that innervate the caudate and the putamen. Studies in animals suggest that fetal …
neurons that innervate the caudate and the putamen. Studies in animals suggest that fetal …
Bromocriptine as primary therapy for prolactin-secreting macroadenomas: results of a prospective multicenter study
…, R Jaffe, G Joplin, RJ Robbins, J Tyson… - Obstetrical & …, 1986 - journals.lww.com
The effectiveness of bromocriptine in reducing tumor size has not been evaluated
systematically, nor has its use as primary therapy for prolactin-secreting macroadenomas been …
systematically, nor has its use as primary therapy for prolactin-secreting macroadenomas been …
Aging and hypothalamic-pituitary-adrenal response to challenge in humans
TE Seeman, RJ Robbins - Endocrine reviews, 1994 - academic.oup.com
AGING is a multifactorial process that results in heterogeneous patterns of progressive morbidity
and disability (1–3). This complex process is influenced by multiple internal homeostatic …
and disability (1–3). This complex process is influenced by multiple internal homeostatic …
Prognostic Value of[ 18F]Fluorodeoxyglucose Positron Emission Tomographic Scanning in Patients with Thyroid Cancer
…, H Macapinlac, J Rosai, RJ Robbins - The Journal of …, 2000 - academic.oup.com
Poorly differentiated thyroid cancer lesions often lose the ability to concentrate radioactive [
131 I]iodine (RAI) and exhibit increased metabolic activity, as evidenced by enhanced …
131 I]iodine (RAI) and exhibit increased metabolic activity, as evidenced by enhanced …
Patient-specific dosimetry for 131I thyroid cancer therapy using 124I PET and 3-dimensional-internal dosimetry (3D-ID) software
…, EF Mun, A Barth, RJ Robbins… - Journal of Nuclear …, 2004 - Soc Nuclear Med
Compared with conventional, whole-organ, S-factor-based dosimetry, 3-dimensional (3D),
patient-specific dosimetry better accounts for radionuclide distribution and anatomic patient …
patient-specific dosimetry better accounts for radionuclide distribution and anatomic patient …
[18F]-2-Fluoro-2-Deoxy-d-Glucose Positron Emission Tomography Localizes Residual Thyroid Cancer in Patients with Negative Diagnostic 131I Whole Body Scans …
…, RD Finn, J Rosai, RJ Robbins - The Journal of …, 1999 - academic.oup.com
Progressive dedifferentiation of thyroid cancer cells leads to a loss of iodine-concentrating
ability, with resultant false negative, whole body radioactive iodine scans in approximately 20…
ability, with resultant false negative, whole body radioactive iodine scans in approximately 20…
The evolving role of 131I for the treatment of differentiated thyroid carcinoma
RJ Robbins, MJ Schlumberger - Journal of Nuclear Medicine, 2005 - Soc Nuclear Med
The use of radioactive iodine ( 131 I) for the treatment of thyroid carcinoma has changed
over the past 50 y. These changes are based on increasing awareness of the biophysical …
over the past 50 y. These changes are based on increasing awareness of the biophysical …